...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease

Cottenmouth asked: "Is this the information that has been dangled in front of us without being revealed for a very long time?  It seems to me that we have been waiting for the results for over a year now."

As Jonzobot posted "Nothing we didn't know already, but it's nice to have the kidney substudy finally peer-reviewed and published. I was seriously wondering why it wasn't yet."

BDAZ

 

Share
New Message
Please login to post a reply